Amento; Edward P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Amento; Edward P..The latest application filed is for "methods of modulating apoptosis by administration of relaxin agonists or antagonists".

Company Profile

0.5.5

Amento; Edward P. - Portola Valley CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of modulating apoptosis by administration of relaxin agonists or antagonists Grant 9,534,034 - Amento , et al. January 3, 2	2017-01-03
Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists App 20120238499 - Amento; Edward P. ; et al.	2012-09-20
Methods of modulating apoptosis by administration of relaxin agonists or antagonists Grant 8,119,136 - Amento , et al. February 21, 2	2012-02-21
Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists App 20110059108 - Amento; Edward P. ; et al.	2011-03-10
Methods of modulating apoptosis by administration of relaxin agonists or antagonists Grant 7,833,526 - Amento , et al. November 16, 2	2010-11-16
Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists App 20080085275 - Amento; Edward P. ; et al.	2008-04-10
Methods of modulating apoptosis by administration of relaxin agonists or antagonists App 20050032683 - Amento, Edward P. ; et al.	2005-02-10
Low dose IFN-gamma compositions and their use for treatment of interferon-sensitive diseases App 20040081635 - Cummins, Joseph M. ; et al.	2004-04-29
Method of predisposing mammals to accelerated tissue repair Grant 5,108,989 - Amento , et al. April 28, 1	1992-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.